Sprinter Health’s $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel. The post Sprinter Health Raises $55M to Expand Home Health Services for Health Plans appeared first on MedCity News.
Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…
Perhaps the most significant health policy of our time, it revolutionized coverage and access, as well as the way healthcare companies communicated. With its future uncertain, now is the time to look back on how it shaped a new era of healthcare marketing strategy and messaging. The post The Affordable Care Act’s Lasting Impact On Healthcare…
Breakthroughs in synthetic biology could help accelerate advances in applications from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products. The post Driving Synthetic Biology Forward Through Adoption of Technology Enabling Rapid DNA and mRNA Synthesis appeared first on MedCity News.
[Sponsored] The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer. The post Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies appeared first on MedCity News.
With Medbridge’s new motion capture capabilities, patients can get more accurate feedback on therapeutic exercises while using their mobile phone or computer’s camera. The post Medbridge Announces New AI-Powered Motion-Capture Capabilities for MSK appeared first on MedCity News.
Israeli cancer diagnostics startup SpoititEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year. The post Meet the Startup Using…
Emrelis, an antibody drug conjugate developed by AbbVie, is now FDA approved for patients whose non-small cell lung cancer overexpresses the protein c-Met. The pharma company said this ADC is its first internally developed solid tumor medicine as well as its first solid tumor FDA approval in lung cancer. The post AbbVie’s Solid Tumor Strategy…
When a water main broke at 5 a.m. and released over 1,000,000 gallons of water, flooding multiple hospital buildings, Crothall’s dedicated EVS team jumped into action. The flooding occurred at Allegheny General Hospital in Pittsburgh on Dec. 4, 2024 But thanks to 12 Crothall EVS floor technicians, the hospital continued to operate as usual, only…
This year, Compass Group and Crothall Healthcare proudly reached the global stage at the 2025 Schneider Electric Paris Marathon through Pierre-Louis Ledent, who represented our organizations while supporting our valued partner and client, Team Allied Services. “Running for a cause gives a much deeper meaning to performance,” Pierre-Louis explained. “As someone living with a chronic…